MGMT and pituitary tumor: Thus far, MGMT expression, rather than promoter methylation, appears to better correlate with TMZ response in pituitary adenomas; however, a limited number of studies have examined this relationship, and TMZ is still administered, particularly in the context of aggressive pituitary tumors, regardless of MGMT status (24, 93).